8.4 End-of-Life Care, Ethics, and Quality Improvement

End-of-Life Care and Terminal Weaning

When a patient's prognosis is futile or treatment aligns poorly with their advanced directives, the focus of care shifts from curative to palliative.

Terminal Weaning / Withdrawal of Life Support

Terminal weaning is the intentional withdrawal of mechanical ventilation in a patient who is expected to expire. The primary goal is absolutely not successful extubation; the goal is patient comfort and the prevention of suffering (dyspnea and air hunger).

• Preparation: The family should be counseled on what to expect (e.g., agonal breathing, skin color changes). All alarms and unnecessary monitors (EKG, SpO2) should be silenced or turned off to provide a peaceful environment.
• Pharmacology: Prior to extubation, the patient is preemptively treated with analgesics (opioids like morphine or fentanyl) to blunt the sensation of dyspnea, and sedatives (benzodiazepines like midazolam) to reduce anxiety. The RT and RN work together to titrate these medications; respiratory depression is an accepted side effect, not a complication, under the ethical principle of the "Double Effect."
• Procedure: Once the patient is comfortable, the RT quickly deflates the cuff and removes the endotracheal tube. Oxygen is often provided via a nasal cannula purely for comfort, not to correct hypoxia. Secretions can be managed with anticholinergic medications (e.g., scopolamine patches) to dry them up, avoiding traumatic deep suctioning.

Medical Ethics in the ICU

Respiratory therapists frequently navigate complex ethical terrain. Clinical decisions are guided by four core ethical principles:

1. Autonomy: The right of the patient (or their legally authorized surrogate) to make informed decisions about their healthcare, including the right to refuse life-saving treatment.
2. Beneficence: The obligation to act in the best interest of the patient, providing interventions that carry a positive balance of benefits over harms.
3. Non-maleficence: The obligation to "do no harm." This includes avoiding treatments that cause suffering without a realistic chance of clinical benefit (medical futility).
4. Justice: The fair and equitable distribution of medical resources, regardless of a patient's socioeconomic status or background.

Surrogate Decision Making

When a patient lacks decisional capacity, healthcare providers turn to an Advanced Directive (Living Will) or a designated Healthcare Power of Attorney. If none exists, state laws dictate a hierarchy of surrogate decision-makers (usually spouse, then adult children, then parents).

Organ Donation

Organ donation transforms end-of-life tragedies into life-saving opportunities for others. Hospital staff are legally required to notify the regional Organ Procurement Organization (OPO) when specific "clinical triggers" are met.

• Clinical Triggers: Typically include an intubated patient with a severe neurological injury and a Glasgow Coma Scale (GCS) score of ≤ 5, or the absence of brainstem reflexes.
• Brain Death Testing: Includes apnea testing (conducted by the RT and physician) to prove the absence of respiratory drive despite severe hypercapnia (PaCO2 > 60 mmHg or 20 mmHg above baseline).
• Donor Management: Once brain death is declared and consent is obtained, the patient is technically deceased, but somatic functions are maintained to preserve the organs. The RT's role is critical here: maintaining lung-protective ventilation, optimizing oxygenation for organ perfusion, and managing aggressive fluid/vasopressor therapies, as brain death invariably leads to severe hemodynamic instability (loss of sympathetic tone).

Quality Improvement: VAE and VAP Bundles

Quality improvement initiatives focus on reducing preventable harm. For the RT, the most critical metric is the prevention of Ventilator-Associated Events (VAEs), specifically Ventilator-Associated Pneumonia (VAP).

VAP is a nosocomial infection that develops >48 hours after intubation. It significantly increases mortality, length of stay, and hospital costs. To combat VAP, hospitals employ "Bundles"—groups of evidence-based interventions that, when executed together, yield better outcomes than when implemented individually.

The VAP Prevention Bundle

The standard VAP bundle components heavily involve respiratory care:

1. Elevation of the Head of the Bed (HOB): Maintained between 30 and 45 degrees to prevent gastroesophageal reflux and micro-aspiration of gastric contents.
2. Daily Sedation Vacations and SBTs: Minimizing the duration of mechanical ventilation is the most effective way to prevent VAP.
3. Oral Care with Chlorhexidine: Regular oral hygiene decreases the bacterial load in the oropharynx, preventing heavily colonized secretions from slipping past the ETT cuff.
4. Peptic Ulcer Disease (PUD) Prophylaxis: (e.g., H2 blockers or PPIs) to prevent stress ulcers, though this must be balanced against the risk of raising gastric pH, which allows bacterial overgrowth.
5. Deep Vein Thrombosis (DVT) Prophylaxis: (e.g., sequential compression devices or subcutaneous heparin).
6. Subglottic Suctioning: Using specialized endotracheal tubes (like the CASS tube - Continuous Aspiration of Subglottic Secretions) that have an extra lumen ending just above the cuff. This allows continuous or intermittent suctioning of the pooled secretions that gather above the cuff, preventing them from micro-aspirating into the lungs.